Skip to content
Save up to 80% Fast & Discrete Delivery
Contrave
Quality products
Fast & Discrete Delivery
Money-back guarantee

Contrave

4.5 (3 customer reviews)
Delivery: from 4 days
Payment
24/7 Support
Active ingredient: Bupropion

Free delivery on orders from AED 860.00, free express delivery from AED 1,290.00

256-bit SSL
Certified pharmacy
Money-back guarantee

Contrave supports long-term weight management alongside a reduced-calorie eating plan and increased physical activity. Its combination targets hunger, cravings, reward-seeking behaviour, and the tendency to continue eating after physical hunger has eased.

Product information

Taken orally as extended-release tablets, Contrave is used for long-term weight management in adults with obesity or overweight linked to weight-related health conditions. It combines naltrexone hydrochloride and bupropion hydrochloride to address hunger, food cravings, reward-seeking behaviour, and continued eating after physical hunger has eased. The regimen for the chosen strength is confirmed with a healthcare professional before starting.

Ingredients

Contrave contains two active substances: naltrexone hydrochloride and bupropion hydrochloride. It is a fixed-dose extended-release tablet, meaning the ingredients are released gradually rather than all at once. This controlled release supports twice-daily dosing and must remain intact during use.

Active pharmaceutical ingredients

Bupropion is an aminoketone antidepressant that also affects appetite and reward signalling. Naltrexone is an opioid receptor antagonist, meaning it blocks opioid receptors involved in the brain’s feedback system.

Together, naltrexone/bupropion works differently from medicines that act mainly through gut hormone receptors. The combination targets hunger, craving, reward-seeking behaviour, and the tendency to continue eating after physical hunger has eased.

Contrave is an extended-release tablet. Splitting, crushing, or chewing it can release too much medicine at once and raises the risk of adverse effects, including seizures.

Therapeutic indications

Contrave is used alongside a reduced-calorie eating plan and increased physical activity for long-term weight management in adults with:

  • Obesity, generally defined as a body mass index of 30 kg/m² or above.
  • Overweight, generally a body mass index of 27 kg/m² or above, when linked with conditions such as high blood pressure, type 2 diabetes, or abnormal blood lipids.
  • Persistent food cravings or appetite dysregulation that make lifestyle changes difficult to sustain.

The WHO describes obesity as a chronic disease associated with higher cardiometabolic risk, not simply a matter of willpower or personal discipline [1]. Contrave supports behavioural changes; it does not replace them.

Dosage and administration

Contrave tablets are swallowed whole with water. Treatment uses gradual dose escalation because naltrexone/bupropion can cause nausea, headache, insomnia, and dizziness when introduced too rapidly.

The regimen for the chosen strength is confirmed with a healthcare professional before starting, especially when there is high blood pressure, kidney disease, liver disease, depression, or use of other medicines.

Treatment period Tablet schedule Daily total
Week 1 One tablet in the morning One tablet
Week 2 One tablet in the morning and one in the evening Two tablets
Week 3 Two tablets in the morning and one in the evening Three tablets
Week 4 onward Two tablets in the morning and two in the evening Four tablets

Do not take more than two tablets at one time. Doses should be spaced through the day, rather than taken together late in the evening. Bupropion can disturb sleep, so an evening dose taken close to bedtime may be troublesome for some people.

If a dose is missed, skip it and take the next scheduled dose. Do not take an extra tablet to catch up. Taking more than prescribed can increase seizure risk.

Set two recurring reminders at consistent morning and evening times. People often remember the first dose but miss the evening dose when work, travel, or family routines change.

FDA prescribing information states that response should be reassessed after 16 weeks of treatment. If meaningful weight loss has not occurred, continuing therapy is unlikely to produce a useful long-term result [2].

When not to use it

Contrave must not be used in the following situations:

  • Uncontrolled high blood pressure.
  • Current use of opioid medicines, opioid dependence, or acute opioid withdrawal.
  • Use of a monoamine oxidase inhibitor, known as an MAOI, within the previous 14 days.
  • Use of another medicine containing bupropion.
  • Abrupt stopping of alcohol, benzodiazepines, barbiturates, or certain anti-seizure medicines.
  • Pregnancy.

Bupropion lowers the seizure threshold. Risk rises with excess alcohol use, abrupt alcohol withdrawal, eating disorders, head injury, certain antipsychotics, stimulant medicines, and medicines that also contain bupropion.

Naltrexone blocks opioid receptors. This can reduce the effect of opioid pain relief and creates a complex problem if emergency analgesia is needed. Planned surgery or dental procedures should be discussed in advance when opioid pain treatment may be required.

Bupropion can interact with medicines metabolised through the CYP2D6 enzyme pathway, including some antidepressants, antipsychotics, beta-blockers, and antiarrhythmics. It may also interact with medicines that lower seizure threshold.

When this is not for you

This medication is not for you if you have a seizure disorder or a past diagnosis of bulimia nervosa or anorexia nervosa. These conditions increase the seizure risk associated with bupropion.

Possible side effects

Nausea is the most common reason people find the early titration phase difficult. Constipation, headache, vomiting, dry mouth, dizziness, insomnia, anxiety, sweating, and increased blood pressure can also occur. These effects often appear during dose escalation rather than after the maintenance schedule has been stable for some time.

More serious reactions need prompt clinical assessment:

  • Seizure, fainting, severe confusion, or loss of consciousness.
  • Severe headache, chest pain, breathlessness, or symptoms of markedly raised blood pressure.
  • New agitation, aggressive behaviour, worsening depression, suicidal thoughts, or unusual changes in mood.
  • Severe abdominal pain, persistent vomiting, or signs of an allergic reaction such as facial swelling or breathing difficulty.
  • Sudden opioid withdrawal symptoms in a person who has recently used opioid pain medicine, opioid cough medicine, or opioid substitution treatment.

Blood pressure and pulse deserve attention. Contrave can raise both, especially during the first three months. The FDA label advises measuring blood pressure and pulse before treatment and periodically during treatment, with extra care in people with controlled hypertension [3].

Tell the prescriber about every opioid-containing medicine, including painkillers and cough treatments. Naltrexone can block opioid effects and may trigger abrupt withdrawal in opioid-dependent people.

How it affects the body

Contrave acts in two connected brain systems: the hypothalamus, which regulates appetite and energy balance, and the mesolimbic reward system, which influences motivation and food cravings. Bupropion stimulates pro-opiomelanocortin, or POMC, neurons. These neurons send signals that can reduce food intake.

Naltrexone prevents beta-endorphin from switching those POMC neurons back down too quickly. The result is a longer appetite-regulating signal than bupropion alone can provide. This is why the two medicines are paired in one tablet.

The reward pathway matters as much as hunger for many people. A person may have eaten enough yet still feel a strong pull toward highly rewarding foods. Contrave may reduce that pull, though the response varies between individuals.

Common mistakes

  • Starting with the full dose instead of following the four-week escalation schedule.
  • Crushing tablets because swallowing feels inconvenient.
  • Taking both daily doses together.
  • Taking an evening dose close to bedtime despite new insomnia.
  • Using opioid pain relief without considering naltrexone’s opioid-blocking action.
  • Ignoring repeated high blood pressure readings, palpitations, or major mood changes.
  • Continuing treatment indefinitely despite no meaningful response after the planned review point.

One subtle mistake is assuming nausea means the medicine is harming the stomach. Nausea is common early on, yet severe, persistent, or worsening vomiting needs medical review rather than simply pushing through.

Comparison

Weight-management medicines differ in route, target, adverse-effect pattern, and suitability for coexisting conditions. Contrave is the oral dual-agent option among commonly used approaches, aimed mainly at appetite regulation and cravings.

Treatment approach Main mechanism Practical profile
Naltrexone/bupropion Central appetite and reward-pathway modulation Oral extended-release tablets; nausea, insomnia, and blood-pressure elevation may limit use
GLP-1 receptor agonists Mimic gut hormones that improve fullness and glucose regulation Usually injectable; gastrointestinal effects are common
Orlistat Reduces dietary fat absorption in the gut Oral; oily stools and urgency can occur after high-fat meals

GLP-1 receptor agonists may be preferred when type 2 diabetes and the need for substantial weight reduction are central treatment priorities. Orlistat avoids central nervous system effects but can be inconvenient when meals contain more fat. Contrave can be a reasonable option when cravings, snacking, and reward-driven eating are prominent barriers.

NICE guidance on overweight and obesity management places pharmacotherapy within a long-term plan that includes nutrition, activity, behavioural support, and review of medical risk factors [4].

What doctors say

In clinical practice, prescribers tend to focus less on the number on the scale during the first days and more on tolerability, blood pressure, sleep, mood, and cravings. A person who feels less compelled to snack in the evening may be responding well before major weight change is visible.

Doctors also look for a measurable response after the full regimen has had time to work. Continuing a medicine that causes persistent nausea or insomnia without a meaningful benefit is rarely a good trade-off.

Contrave suits a defined clinical pattern. It may be useful for adults whose eating is strongly influenced by cravings and reward, yet it is a poor fit for anyone using opioids or carrying significant seizure risk.

The Ministry of Health and Prevention, MOHAP, supports chronic disease management that addresses obesity-related risks such as diabetes and hypertension. Monitoring blood pressure, glucose status, sleep, and mental wellbeing gives treatment a clearer clinical purpose than focusing on body weight alone.

Comparison

Ayurslim

Active ingredient: Ayurslim
60caps
From AED 546.10
bottles
3.5 (5)

Contrave Current

Active ingredient: Bupropion
98mg
From AED 606.30
pills
4.5 (3)

Comparison table: Weight Loss

Common questions

Can Contrave tablets be split, crushed, or chewed?

No. Contrave is an extended-release tablet, so splitting, crushing, or chewing disrupts the controlled-release design and may expose the body to medicine too quickly. That can increase adverse effects and seizure risk. The FDA product information published in 2023 instructs users to swallow tablets whole. The same instruction applies throughout the treatment course.

Can alcohol be used while taking Contrave?

Alcohol can increase the chance of seizures with bupropion, especially with heavy use or abrupt alcohol withdrawal. It can also worsen dizziness, impaired concentration, sleep disturbance, and mood symptoms. The WHO’s 2024 alcohol guidance identifies alcohol as a meaningful contributor to several health risks, which matters when managing body weight and blood pressure. Avoiding alcohol binges is especially important during Contrave treatment.

Can Contrave be combined with opioid medicines or opioid-based cough products?

No routine combination should be assumed safe because naltrexone blocks opioid receptors. It may reduce opioid pain relief and can trigger sudden withdrawal in people who are physically dependent on opioids. FDA prescribing information describes opioid use as a key contraindication for naltrexone/bupropion therapy. This includes prescribed pain medicines as well as opioid-containing cough preparations.

Does a seizure disorder rule out Contrave?

Yes. A current or previous seizure disorder rules out Contrave because bupropion can lower the seizure threshold. Bulimia nervosa and anorexia nervosa also rule it out for the same reason. The EMA’s 2023 product information for bupropion-containing medicines lists seizure risk as a central safety concern. A history of serious head trauma or medicines that lower seizure threshold also requires careful clinical assessment.

Can older adults use Contrave?

Older adults may use Contrave when the expected benefit outweighs the risks, though treatment needs closer review of blood pressure, kidney function, liver function, sleep, mood, and other medicines. Polypharmacy is common in later life, and bupropion-related CYP2D6 interactions can become clinically relevant. NICE guidance updated in 2025 recommends individual assessment of frailty, comorbidities, and treatment burden when managing overweight and obesity in older adults. Opioid use for chronic pain is another frequent reason Contrave may be unsuitable.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Sources

  1. World Health Organization (2024). Obesity and overweight.
  2. U.S. Food and Drug Administration (2023). CONTRAVE: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release Tablets, for Oral Use: Prescribing Information.
  3. U.S. Food and Drug Administration (2023). Drug Safety-related Labeling Changes: CONTRAVE.
  4. National Institute for Health and Care Excellence (2025). Overweight and obesity management: NICE guideline NG246.

Reviews: Contrave

Ahmed, 64
Al Majaz
Almost three months
Verified
Rating: 5 out of 5
I used Contrave for almost three months and noticed that evening snacking stopped feeling automatic by the third week. I still planned my meals, but I was satisfied because portions became easier to manage and my progress felt steady.
31 Oct 2026
Joel, 49
Al Ain
After the first month
Verified
Rating: 3.5 out of 5
I started with the gradual schedule and my appetite was lower after the first month. The nausea during the dose increase was inconvenient for about a week, especially on rushed mornings, but it settled after I changed my breakfast routine.
7 Nov 2026
Majid, 61
Dibba Al-Fujairah
Ten weeks
Verified
Rating: 5 out of 5
I took the tablets consistently for ten weeks and the biggest difference was fewer cravings for sweets after dinner. The result was practical rather than dramatic, and I was pleased that I could follow my eating plan without feeling constantly preoccupied with food.
12 Oct 2026
Get our free app Shop faster and track your orders 3.9 · 268 reviews Install